Learn How Multiomics Drives Biotherapeutic Discovery and Development
eBook

Advancing Biotherapeutics with Multiomics

Explore how biomolecular processes drive health and disease.

Share

Multiomic technologies—including genomics, transcriptomics, proteomics, metabolomics, epigenomics, and microbiomics—advance the way scientists develop biotherapeutics. A systems level approach to studying the underlying biomolecular mechanisms of health and disease is paving the way for new biomarker, diagnostic, and therapeutic development. To support these advances and accelerate biomedical breakthroughs, researchers turn to new approaches for automating multiomic workflows.

Download this ebook from Tecan to learn how automated systems, such as liquid handling platforms, improve the reproducibility, reliability, and throughput of -omic techniques.

Top Image Credit:

istock

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies